Parent and practitioner experiences of opt-out consent in neonatal intensive care: a mixed methods study within a

Tracy Mitchell1, Izabela Andrzejewska2, Cheryl Battersby3

  • 1Public Health, Policy and Systems, University of Liverpool, Liverpool, UK.

Insights

Verbal opt-out consent is acceptable in low-risk neonatal trials, but timing is crucial. Parents and staff found the neoGASTRIC trial

Area of Science:

  • Neonatal research ethics
  • Clinical trial recruitment strategies
  • Informed consent processes

Background:

  • Verbal opt-out consent is utilized in neonatal trials to improve efficiency and representativeness.
  • Limited understanding exists regarding the operationalization and acceptability of opt-out consent in multicenter neonatal trials.
  • The neoGASTRIC trial investigated routine versus no routine measurement of gastric contents in preterm infants.

Purpose of the Study:

  • To explore parental and staff views and experiences of verbal opt-out consent within the neoGASTRIC trial.
  • To assess the acceptability and operationalization of opt-out consent in a multicenter neonatal setting.
  • To identify factors influencing the effectiveness of opt-out consent procedures in neonatal research.

Main Methods:

  • A mixed-methods process evaluation was conducted, incorporating questionnaires, interviews, and focus groups.
  • The study involved 253 participants (167 staff and 86 parents) across four UK neonatal units.
  • Data collection focused on participants' experiences and perceptions of the verbal opt-out consent process.

Main Results:

  • Both parents and staff generally supported opt-out consent, viewing the neoGASTRIC interventions as low-risk and non-invasive.
  • Parents valued timely research discussions, though awareness of study information banners/posters was low (21%).
  • Variations in operationalizing opt-out consent were observed, with some parents feeling overwhelmed when approached during or shortly after labor; some staff used modified opt-in approaches.

Conclusions:

  • Appropriately timed verbal opt-out consent is acceptable and proportionate for low-risk neonatal trials comparing accepted clinical practices.
  • The findings from the neoGASTRIC trial provide valuable insights for refining consent procedures in similar neonatal research settings.
  • This study highlights the importance of considering parental capacity and the timing of information provision in opt-out consent models.
Abstract

Related Concept Videos

Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
1.0K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
24.0K